3rd Quarter - Report
SUN PHARMACEUTICAL INDUSTRIES, INC. for SUN PHARMACEUTICAL INDUSTRIES, INC.
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 5526 - Biosimilar Red Tape Elimination Act; all provisions. S. 1414 - Expedited Access to Biosimilars Act; all provisions. S. 2658 - Medication Affordability and Patent Integrity Act; all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY ALLEN | — |
Trade (domestic/foreign) TRD
Issues related to Section 232 pharmaceutical tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY ALLEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.